Lipoxygenase
Lipoxygenase(脂氧合酶)
Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid. Thre are six LOX isoforms have been found in the humans and mice. 5-Lipoxygenase (5-LOX) is a distinct isoform playing an important role in asthma and inflammation. 5-LOX causes the constriction of bronchioles in response to cysteinyl leukotrienes such as LTC4, thus leading to asthma. 5-LOX also induces neutrophilic inflammation by its recruitment in response to LTB4. 12-Lipoxygenase (12-LOX) is an isoform expressed in epithelial cells and myeloid cells including platelets. 12-LOX can be found in the epithelial cells of the skin. 12-LOX is a potential target for novel anti-platelet therapeutics.15-Lipoxygenase (15-LOX) is expressed in epithelial cells and leukocytes, has different substrate specificity in the humans and mice.15-LOX-1 is a target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.
Lipoxygenase 相关产品(254)
- GC408305,6-dehydro Arachidonic AcidCAS: 58688-54-3纯度: >98.00%
An analog of arachidonic acid with acetylene in the 5,6 position
- GC4097110(S),17(S)-DiHDHACAS: 871826-47-0纯度: >98.00%
A DHA derivative with anti-inflammatory and anti-platelet activity
- GC40982Resolvin D5CAS: 578008-43-2纯度: >95.00%
A potent anti-inflammatory, pro-resolving lipid mediator
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40542 | 9(R)-HODE | 10075-11-3 | >98.00% | |
A linoleic acid metabolite | ||||
| GC40609 | Lipoxin A5 | 110657-98-2 | >95.00% | |
An EPA-derived bronchoconstrictor | ||||
| GC40631 | Leukotriene B4-3-aminopropylamide | 89596-43-0 | >95.00% | |
A potent BLT 1 receptor ligand | ||||
| GC40697 | DDA | 25152-84-5 | >98.00% | |
A lipid decomposition product with cancer inhibiting activity | ||||
| GC40784 | 5(Z),8(Z),14(Z)-Eicosatrienoic Acid | 90105-02-5 | >98.00% | |
A polyunsaturated fatty acid | ||||
| GC40828 | (±)5-HETE lactone | 73279-37-5 | >98.00% | |
A 5-LO inhibitor | ||||
| GC40829 | 5(S)-HETE lactone | 127708-42-3 | >98.00% | |
A potential 5-LO inhibitor | ||||
| GC40830 | 5,6-dehydro Arachidonic Acid | 58688-54-3 | >98.00% | |
An analog of arachidonic acid with acetylene in the 5,6 position | ||||
| GC40839 | 15(S)-HETE methyl ester | 70946-44-0 | >98.00% | |
A synthetic derivative of 15(S)-HETE | ||||
| GC40840 | Leukotriene A3 methyl ester | 83851-38-1 | >97.00% | |
A metabolically stable form of LTA 3 | ||||
| GC40971 | 10(S),17(S)-DiHDHA | 871826-47-0 | >98.00% | |
A DHA derivative with anti-inflammatory and anti-platelet activity | ||||
| GC40975 | 17(S)-HpDHA | 123673-33-6 | >98.00% | |
A mono-oxygenation product of DHA | ||||
| GC40978 | 7-epi Maresin 1 | 1268720-66-6 | >95.00% | |
An inactive Maresin 1 epimer | ||||
| GC40980 | Maresin 2 | 1639809-46-3 | ≥95.00% | |
A 13R,14S-dihydroxy DHA produced by macrophages | ||||
| GC40981 | Protectin D1 | 660430-03-5 | >98.00% | |
A specialized pro-resolving mediator | ||||
| GC40982 | Resolvin D5 | 578008-43-2 | >95.00% | |
A potent anti-inflammatory, pro-resolving lipid mediator | ||||
| GC41044 | CAY10583 | 862891-27-8 | >98.00% | |
A selective BLT 2 agonist | ||||
| GC41095 | 12(S)-HpEPE | 103239-14-1 | >96.00% | |
A 12-LO product derived from EPA | ||||
| GC41096 | 12-oxo Leukotriene B4 | 136696-10-1 | >90.00% | |
A natural metabolite of LTB 4 | ||||
| GC41100 | 14,15-dehydro Leukotriene B4 | 114616-11-4 | >97.00% | |
A LTB 4 receptor antagonist | ||||
| GC41101 | 15(S)-HpEPE | 125992-60-1 | >98.00% | |
Produced by the action of 15-lipoxygenase on EPA | ||||
| GC41105 | 5(S)-HpEPE | 143292-98-2 | >95.00% | |
Produced by the action of 5-LO on EPA; LTA 5 precursor | ||||
| GC41107 | Leukotriene B5 | 80445-66-5 | >98.00% | |
A leukotriene | ||||
| GC41122 | 12(S)-HpETE | 71774-10-2 | >98.00% | |
A 12-LO metabolite of arachidonic acid | ||||
